1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Office-wide: BTO (HR001126S0003) is a grant from Defense Advanced Research Projects Agency (DARPA) that funds research leveraging biological properties and processes to protect the nation's warfighters. DARPA's Biological Technologies Office (BTO) solicits proposals through a Broad Agency Announcement via Cooperative Agreement.
The program is open to all responsible sources capable of satisfying the government's needs, including universities, industry, and other organizations. Research must go beyond evolutionary improvements to existing practice. Applications are due September 30, 2026.
No cost sharing or matching is required.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DARPA - Biological Technologies Office Document Type:Grants Notice Funding Opportunity Number:HR001126S0003 Funding Opportunity Title:Biological Technologies Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Other Procurement Contract Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards: Assistance Listings:12.
910 -- Research and Technology Development Cost Sharing or Matching Requirement:No Last Updated Date:Oct 01, 2025 Original Closing Date for Applications:Sep 30, 2026 See Full Announcement for details. Current Closing Date for Applications:Sep 30, 2026 See Full Announcement for details.
Archive Date:Oct 30, 2026 Estimated Total Program Funding: Eligible Applicants:Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Information on Eligibility:All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information.
## Additional Information Agency Name:DARPA - Biological Technologies Office Description:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
Link to Additional Information:SAM. gov Contract Opportunities Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: ## Similar Opportunities (identified by AI)
According to the current listing, eligibility includes: Proposers can be from universities, industry, and government. Eligibility is typically broad for DARPA BAAs, focusing on scientific and technical merit. Specific requirements would be detailed in the full BAA. Confirm the full requirements in the official notice before applying.
Applications for Office-wide: BTO (HR001126S0003) are due September 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Office-wide: BTO (HR001126S0003) is funded by Defense Advanced Research Projects Agency (DARPA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read articleRelease 6's SBIR topics got the attention. Its three STTR topics — SHIELDER, fuel-flexible electric propulsion, and hypersonic wind tunnel noise diagnostics — are all Direct-to-Phase-II, all require a research institution to perform at least 30 percent of the work, and all close October 21, 2026. The feasibility gates are the real filter.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read article